CIK 0000200406 · Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221024240
- Phone
- 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,898,386
- in 3 filings
Net −$16,898,386. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-15 | Decker Robert J VP Corporate Controller | Option exercise · Restricted Share Units | −339 | 338 | ||
| 2026-02-15 | Decker Robert J VP Corporate Controller | Option exercise · Restricted Share Units | −344 | 687 | ||
| 2026-02-15 | Decker Robert J VP Corporate Controller | Grant or award · Employee Stock Options (Right to Buy) | +4,871 | 4,871 | ||
| 2026-02-15 | Decker Robert J VP Corporate Controller | Grant or award · Restricted Share Units | +700 | 700 | ||
| 2026-02-15 | REED JOHN C EVP, Innovative Medicine, R&D | Option exercise | +1,349 | 12,007 | ||
| 2026-02-15 | REED JOHN C EVP, Innovative Medicine, R&D | Shares withheld for taxes | −385 | $243.45 | $94K | 11,622 |
| 2026-02-15 | REED JOHN C EVP, Innovative Medicine, R&D | Option exercise | +1,847 | 13,469 | ||
| 2026-02-15 | REED JOHN C EVP, Innovative Medicine, R&D | Shares withheld for taxes | −528 | $243.45 | $129K | 12,941 |
| 2026-02-15 | REED JOHN C EVP, Innovative Medicine, R&D | Option exercise · Restricted Share Units | −1,349 | 1,349 | ||
| 2026-02-15 | REED JOHN C EVP, Innovative Medicine, R&D | Option exercise · Restricted Share Units | −1,847 | 3,692 | ||
| 2026-02-15 | REED JOHN C EVP, Innovative Medicine, R&D | Grant or award · Employee Stock Options (Right to Buy) | +49,382 | 49,382 | ||
| 2026-02-15 | REED JOHN C EVP, Innovative Medicine, R&D | Grant or award · Restricted Share Units | +3,546 | 3,546 | ||
| 2026-02-15 | Forminard Elizabeth EVP, Chief Legal Officer | Option exercise | +961 | 23,541 | ||
| 2026-02-15 | Forminard Elizabeth EVP, Chief Legal Officer | Shares withheld for taxes | −492 | $243.45 | $120K | 23,049 |
| 2026-02-15 | Forminard Elizabeth EVP, Chief Legal Officer | Option exercise | +1,063 | 24,112 | ||
| 2026-02-15 | Forminard Elizabeth EVP, Chief Legal Officer | Shares withheld for taxes | −544 | $243.45 | $132K | 23,568 |
| 2026-02-15 | Forminard Elizabeth EVP, Chief Legal Officer | Option exercise · Restricted Share Units | −961 | 961 | ||
| 2026-02-15 | Forminard Elizabeth EVP, Chief Legal Officer | Option exercise · Restricted Share Units | −1,063 | 2,126 | ||
| 2026-02-15 | Forminard Elizabeth EVP, Chief Legal Officer | Grant or award · Employee Stock Options (Right to Buy) | +27,076 | 27,076 | ||
| 2026-02-15 | Forminard Elizabeth EVP, Chief Legal Officer | Grant or award · Restricted Share Units | +1,944 | 1,944 |
Page 7 of 19 · 365 trades